Bicyclic peptide inhibitors of interleukin-23 receptor
Номер патента: EP4370532A2
Опубликовано: 22-05-2024
Автор(ы): Ashok Bhandari, Brian Frederick, Charles HENDRICK, Chengzao Sun, Danila Branca, Elisabetta Bianchi, Jie Zhang, Jing Zhang, Raffaele Ingenito, Raymond J. Patch, Roberto COSTANTE, Sandeep Somani, Santhosh Neelamkavil, Stephanie A. BARROS, Tran Trung Tran
Принадлежит: Janssen Biotech Inc, Protagonist Therapeutics Inc
Опубликовано: 22-05-2024
Автор(ы): Ashok Bhandari, Brian Frederick, Charles HENDRICK, Chengzao Sun, Danila Branca, Elisabetta Bianchi, Jie Zhang, Jing Zhang, Raffaele Ingenito, Raymond J. Patch, Roberto COSTANTE, Sandeep Somani, Santhosh Neelamkavil, Stephanie A. BARROS, Tran Trung Tran
Принадлежит: Janssen Biotech Inc, Protagonist Therapeutics Inc
Реферат: The present invention relates to novel bicyclic peptide inhibitors of the interleukin-23 receptor (IL-23R) or pharmaceutically acceptable salt thereof, corresponding pharmaceutical compositions, methods and/or uses for treatment of autoimmune inflammation and related diseases and disorders.
Bicyclic peptide inhibitors of interleukin-23 receptor
Номер патента: US20240352073A1. Автор: Jie Zhang,Ashok Bhandari,Jing Zhang,Chengzao Sun,Elisabetta Bianchi,Raymond J. Patch,Danila Branca,Brian Frederick,Santhosh Neelamkavil,Raffaele Ingenito,Sandeep Somani,Tran Trung Tran,Roberto COSTANTE,Stephanie A. BARROS,Charles HENDRICK. Владелец: Protagonist Therapeutics Inc. Дата публикации: 2024-10-24.